## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.3% in lower entry zone (4.0-10.0%), top quartile (76th pct) cross-sectional ranking. Caution: MRS_5 (-1.8%) diverging from MRS_20, watch for reversal. Outperforming sector by 5.3%. Caution: momentum weakening (-4.8% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($420.47)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 9)

**1. Synopsys, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - SNPS**
- Source: Morningstar | 20251215T140845 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to shareholders of Synopsys, Inc. (NASDAQ: SNPS) regarding alleged securities law violations. The lawsuit claims that Synopsys made materially false and/or misleading statements concerning the economic impact of its increased focus on AI customers on its Design IP business. Shareholders who purchased SNPS shares between December 4, 2024, and September 9, 2025, are encouraged to contact the firm by the December 30, 2025 deadline to explore lead plaintiff appointment.

**2. SNPS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Synopsys, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: WSYR | 20251215T120846 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Synopsys, Inc. (NASDAQ:SNPS) for alleged violations of federal securities laws. The lawsuit seeks to recover damages for investors who purchased Synopsys securities between December 4, 2024, and September 9, 2025, claiming the company made materially false and misleading statements regarding its business operations and financial prospects, particularly concerning its Design IP business and focus on AI customers. Shareholders suffering losses have until December 30, 2025, to request to be appointed as lead plaintiff.

**3. Levi & Korsinsky Notifies Synopsys, Inc. (SNPS) Shareholders of Class Action Lawsuit and December 30, 2025 Deadline**
- Source: WOODTV.com | 20251214T170933 | Bearish | Relevance: 100%
- Levi & Korsinsky has announced a class action securities lawsuit against Synopsys, Inc. (SNPS) for alleged securities fraud between December 4, 2024, and September 9, 2025. Shareholders who experienced losses during this period are encouraged to seek information about potential recovery, with a deadline of December 30, 2025. The lawsuit alleges that Synopsys made misleading statements regarding financial impacts due to increased focus on AI customers and related business decisions.

**4. SNPS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Synopsys, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!**
- Source: NEWS10 ABC | 20251214T120845 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Synopsys, Inc. (NASDAQ:SNPS), alleging that the company and its officers made materially false and misleading statements to investors between December 4, 2024, and September 9, 2025. The lawsuit claims Synopsys failed to disclose how its increased focus on AI customers negatively impacted its Design IP business economics and financial results. Investors who suffered losses are encouraged to join the case and can request to be appointed as lead plaintiff by December 30, 2025.

**5. SNPS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Synopsys, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!**
- Source: WWLP | 20251214T120837 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Synopsys, Inc. (SNPS) and some of its officers. The lawsuit alleges that Synopsys made materially false and/or misleading statements and failed to disclose adverse facts regarding its business and operations between December 4, 2024, and September 9, 2025. Synopsys shareholders who suffered losses have until December 30, 2025, to request to be appointed as lead plaintiff.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Morgan Stanley | $550 | $510 | +8% |
| 2025-12-11 | JP Morgan | $650 | $600 | +8% |
| 2025-12-11 | Wells Fargo | $500 | $445 | +12% |
| 2025-12-11 | Keybanc | $600 | $575 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Morgan Stanley | main | Overweight |
| 2025-12-11 | JP Morgan | main | Overweight |
| 2025-12-11 | Wells Fargo | main | Equal-Weight |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.54M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Valuation stretched: PEG 6.3x requires aggressive growth execution.
2. Long-term trend broken: trading 7.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 6 raises (avg +8%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 6.26 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Analyst sentiment positive (6 raises, avg +8%). Insider buying signal ($0.5M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $86.3B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.26 |
| Forward P/E | 26.8 |
| Current P/E | 31.5 |
| YoY Growth | 17.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 10.1% to 5.3% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 76th percentile. MRS_5 (-1.8%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 5.6% shows strong absolute momentum above own 20MA. Outperforming sector by 5.3pp, stock-specific strength. Below SMA200 (0.93x), long-term trend not supportive. MACD histogram positive (6.01), confirming momentum. RSI neutral at 56. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: -FTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.31% (CS: 77) | Strong |
| RSI_14 | 55.7 | Neutral |
| MACD Histogram | 6.01 | Bullish |
| vs SMA20 | 1.056x | Above |
| vs SMA50 | 1.037x | Above |
| vs SMA200 | 0.928x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $452.95
- **Stop Loss:** $420.47 (7.2% risk)
- **Target:** $501.67 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 30
- **Position Value:** $13,588.50
- **Portfolio %:** 13.59%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.88 | $2.90 | +0.7% |
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*